玻璃体切割联合人工晶状体植入术治疗糖尿病视网膜病变合并白内障

目的：探讨玻璃体切割联合Ⅰ/Ⅱ期人工晶状体植入术治疗糖尿病视网膜病变合并白内障的临床疗效和安全性。

方法：选取2015-03/2017-04于我院手术治疗糖尿病视网膜病变合并白内障的患者67例76眼，根据手术方式不同分为A组(Ⅰ期玻璃体切割+晶状体超声乳化摘除+硅油填充+人工晶状体植入术，Ⅱ期硅油取出术)和B组(Ⅰ期玻璃体切割+晶状体超声乳化摘除+硅油填充，Ⅱ期硅油取出+人工晶状体植入术)。比较两组患者视力改善、眼压及术后并发症情况。

结果：术后3mo，两组患者视力改善情况无差异(P>0.05)。术前和术后3mo，两组患者眼压无明显变化(P>0.05)。两组患者玻璃体出血(3% vs 5%)、脉络膜出血(0% vs 2%)、视网膜脱落(6% vs 2%)、视网膜裂孔(6% vs 10%)发生率均无明显差异(P>0.05)。

结论：玻璃体切割联合Ⅰ/Ⅱ期人工晶状体植入术治疗糖尿病视网膜病变合并白内障疗效无明显差异。

Vitrectomy combined with intraocular lens implantation for the treatment of diabetic retinopathy complicated with cataract

AIM: To investigate the clinical efficacy and safety of vitrectomy combined with stage I/II intraocular lens implantation for diabetic retinopathy complicated with cataract.

METHODS: Select 67 case(76 eyes)of diabetic retinopathy complicated with cataract patients in the First Affiliated Hospital of Jiamusi University during March 2015 to April 2017 as retrospective analysis. According to different surgical methods, they were divided into group A(stage I vitrectomy + phacoemulsification + silicone oil filling + intraocular lens implantation, phase II silicone oil extraction)and group B(stage I vitrectomy + lens phacoemulsification + silicone oil filling), stage II silicone oil extraction + intraocular lens implantation). The visual acuity improvement, intraocular pressure and postoperative complications were compared between the two groups.

RESULTS: At 3mo after operation, there was no difference in visual acuity between the two groups(P>0.05). There was no significant change in intraocular pressure between the two groups 3mo before and after surgery(P>0.05). Vitreous hemorrhage(3% vs 5%), choroidal hemorrhage(0% vs 2%), retinal detachment(6% vs 2%), retinal tears(6% vs 10%)There was no significant difference in incidence(P>0.05).

CONCLUSION: There was no significant difference in the efficacy of vitrectomy combined with I/II intraocular lens implantation for diabetic retinopathy complicated with cataract.